← Back to All Filings

Former Director Files to Sell $858K in Surgery Partners Stock

Medium SignificanceOctober 21, 2025 at 4:33:17 PM EDT

Surgery Partners, Inc.

$SGRY144CIK: 0001638833

Subscribe to track SGRY

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Former Director Files to Sell $858K in Surgery Partners Stock

Company: Surgery Partners, Inc. (SGRY) Form: 144 | Filed: 2025-10-21 Significance: Medium

Insider: Wayne DeVeydt Title: Former Director

Transaction (Proposed Sale): • Type: Proposed Sale • Shares: 40,863 • Value: $857,524.94 • Price/Share: ~$20.99

Key Insight: While this proposed sale is small (0.03% of market cap), it continues a significant pattern. The same insider has sold over 824,000 shares for ~$19.4M in the past three months.

Market Context: The filing is a notice of proposed sale, indicating intent to sell. The sustained selling by a former director may be of interest to investors monitoring insider sentiment.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: Surgery Partners, Inc. (SGRY)

Executive Summary

  • Trading Significance: Medium
  • Key Takeaway: A former director filed a notice of proposed sale for $858K of stock, which is part of a much larger pattern of selling totaling over $19 million in the last three months.
  • Market Impact: The individual transaction is immaterial, but the cumulative selling activity could be perceived as a bearish signal by the market, warranting monitoring of the stock's price action.

Company Information

FieldValue
CompanySurgery Partners, Inc.
Ticker SymbolSGRY
CIK0001638833
IndustryGeneral Medical & Surgical Hospitals

Insider Information

FieldValue
NameWayne DeVeydt
CIK0001321392
Title/PositionFormer Director
RelationshipFormer Director

Transaction Details

FieldValue
Form Type144 (Notice of Proposed Sale)
Transaction Date2025/10/21 (Approximate Sale Date)
Transaction CodeS (Sale)
Security TypeCommon Stock
Shares Involved40,863
Price Per Share~$20.99 (Calculated)
Total Value$857,524.94
Shares Owned AfterNot Available
Ownership TypeNot Specified

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$857,524.94
% of Market Cap0.032%
Shares Transacted40,863
% of Shares Outstanding0.032%
Post-Transaction OwnershipNot Available
Materiality AssessmentLow (for this single transaction)

Impact Evaluation

  • Market Cap Context: For a company with a $2.64 billion market capitalization, this proposed sale of under $1 million is financially insignificant on its own.
  • Ownership Concentration: Post-transaction ownership is not disclosed in a Form 144, so a change in ownership concentration cannot be calculated.
  • Dilution Impact: Not applicable, as this is a secondary market sale, not an issuance of new shares.
  • Transaction Significance: The significance is elevated from 'Low' to 'Medium' not because of this single transaction's size, but because it is part of a sustained and substantial selling pattern by the insider.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral to Negative
  • Reasoning: A single sale of this size from a former director would typically be neutral. However, the filing reveals a consistent pattern of multi-million dollar sales over the prior three months. This cumulative selling pressure could be interpreted as a bearish signal, suggesting the former insider is systematically liquidating a large position.

Volume & Sentiment

  • Expected Volume Impact: Minimal impact from this single transaction, but the ongoing series of sales contributes to selling pressure.
  • Sentiment Indicator: Bearish. Consistent selling by insiders, even former ones, can weigh on investor sentiment as it may signal a belief that the stock is fully valued or faces headwinds.

Investment Insights

Positive Market Indicators

  • The transaction is being conducted by a former director, which carries less weight than a sale by a current C-suite executive or active board member.

Risk Factors

  • The insider has sold over 824,000 shares for approximately $19.4 million in the 90 days prior to this filing, a substantial liquidation.
  • Such a consistent pattern of selling could indicate the insider's lack of confidence in the company's near-term growth prospects or a belief that the stock's valuation is at a peak.

Key Takeaways

  1. Pattern Over Event: The key story is not the $858K proposed sale but the ~$19.4M in sales over the last three months.
  2. Former Insider Status: The signal is somewhat muted because the seller is a former, not current, director. The reasons for selling could be related to personal financial planning post-departure rather than a view on company performance.
  3. Low Materiality: On a standalone basis, the proposed sale represents a negligible 0.032% of the company's market cap, posing no direct threat to market stability.

Additional Context

Transaction Notes

  • This Form 144 serves as a notice of proposed sale, meaning the shares are intended to be sold at or around the approximate date listed. It does not confirm the transaction has been executed.
Topics:#SECFiling#InsiderTrading#SGRY#StockAlert#Form144#InsiderSell#SurgeryPartners#Investing#MarketAnalysis#HealthcareStocks

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.